A new lawsuit accuses hedge fund manager Bill Ackman and Canadian firm Valeant Pharmaceuticals International Inc. of insider trading in Allergan Inc. stock before their unsuccessful bid to acquire the Botox maker.
Philadelphia’s transit system is taking on Gilead Sciences Inc. over its sky-high pricing of the breakthrough hepatitis C drug Sovaldi.
A computer system was more effective than doctors at recording patient symptoms, highlighting the potential of computers to improve medical results, according to research by Cedars Sinai.
Healthcare giant Kaiser Permanente is facing mounting criticism about the care it provides mental health patients in California.
The chief executive of Los Angeles nutritional products maker Herbalife Ltd. is adding more than $12 million of company stock to his personal holdings, a move the firm said shows his "complete confidence in the continued and future success of the company."
The chief executive of construction services firm Jacobs Engineering Group Inc. is retiring from the Pasadena company because of health issues, the company said.
Retailer AutoZone Stores Inc. should pay $185 million in punitive damages for unlawfully demoting and firing a female employee who complained about gender and pregnancy discrimination, a federal jury in San Diego ruled.
Botox maker Allergan Inc., an Irvine company that started as a purveyor of eye drops and grew into one of the most respected pharmaceutical companies in the country, agreed to be acquired by Irish firm Actavis for $66 billion.